EFS
VRTX icon

Essex Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Essex Financial Services’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$334K Sell
748
-118
-14% -$55K 0.02% 575
2025
Q4 		$393K Buy
866
+48
+6% +$20.7K 0.02% 515
2025
Q3 		$320K Buy
818
+46
+6% +$19.2K 0.02% 568
2025
Q2 		$344K Sell
772
-5
-0.6% -$2.3K 0.02% 509
2025
Q1 		$377K Sell
777
-24
-3% -$11.2K 0.03% 441
2024
Q4 		$323K Sell
801
-155
-16% -$71.8K 0.02% 473
2024
Q3 		$454K Buy
956
+219
+30% +$105K 0.03% 399
2024
Q2 		$343K Buy
737
+60
+9% +$26K 0.03% 450
2024
Q1 		$283K Buy
677
+37
+6% +$15.6K 0.03% 434
2023
Q4 		$260K Sell
640
-11
-2% -$4.06K 0.03% 425
2023
Q3 		$226K Sell
651
-9
-1% -$3.15K 0.03% 421
2023
Q2 		$232K Sell
660
-21
-3% -$7.08K 0.03% 415
2023
Q1 		$215K Sell
681
-52
-7% -$15.6K 0.02% 456
2022
Q4 		$211K Buy
733
+11
+2% +$3.35K 0.02% 448
2022
Q3 		$209K Sell
722
-26
-3% -$7.48K 0.02% 428
2022
Q2 		$211K Sell
748
-76
-9% -$20.3K 0.02% 451
2022
Q1 		$215K Buy
+824
New +$196K 0.02% 464

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Essex Financial Services's VRTX Position: Q1 2026 in Review

Essex Financial Services reduced its Vertex Pharmaceuticals (VRTX) stake by 14% in Q1 2026, selling an estimated $55K and leaving 748 shares worth $334K. The position accounts for 0.02% of the portfolio, ranked #575.

Essex Financial Services first reported a position in VRTX in Q1 2022 and has held it in 17 quarters since. The position peaked at $454K in Q3 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Essex Financial Services held 748 shares of Vertex Pharmaceuticals worth $334K as of Q1 2026.
  • Essex Financial Services sold 118 Vertex Pharmaceuticals shares in Q1 2026, an estimated $55K.
  • Vertex Pharmaceuticals made up 0.02% of Essex Financial Services's portfolio in Q1 2026, its #575 holding.
  • Essex Financial Services first reported a position in Vertex Pharmaceuticals in Q1 2022 and has held it in 17 quarters since.
  • Essex Financial Services's Vertex Pharmaceuticals position peaked at $454K in Q3 2024.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Essex Financial Services's 13F filing for Q1 2026, filed 24 Apr 2026.